These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33671932)

  • 1. Differential Effects of Trp53 Alterations in Murine Colorectal Cancer.
    Betzler AM; Nanduri LK; Hissa B; Blickensdörfer L; Muders MH; Roy J; Jesinghaus M; Steiger K; Weichert W; Kloor M; Klink B; Schroeder M; Mazzone M; Weitz J; Reissfelder C; Rahbari NN; Schölch S
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33671932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a colon cancer GEMM-derived orthotopic transplant model for drug discovery and validation.
    Martin ES; Belmont PJ; Sinnamon MJ; Richard LG; Yuan J; Coffee EM; Roper J; Lee L; Heidari P; Lunt SY; Goel G; Ji X; Xie Z; Xie T; Lamb J; Weinrich SL; VanArsdale T; Bronson RT; Xavier RJ; Vander Heiden MG; Kan JL; Mahmood U; Hung KE
    Clin Cancer Res; 2013 Jun; 19(11):2929-40. PubMed ID: 23403635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Characterization of a Genetic Mouse Model of KRAS Mutated Colorectal Cancer.
    Maitra R; Thavornwatanayong T; Venkatesh MK; Chandy C; Vachss D; Augustine T; Guzik H; Koba W; Liu Q; Goel S
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic
    Boutin AT; Liao WT; Wang M; Hwang SS; Karpinets TV; Cheung H; Chu GC; Jiang S; Hu J; Chang K; Vilar E; Song X; Zhang J; Kopetz S; Futreal A; Wang YA; Kwong LN; DePinho RA
    Genes Dev; 2017 Feb; 31(4):370-382. PubMed ID: 28289141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant p53 Promotes Epithelial Ovarian Cancer by Regulating Tumor Differentiation, Metastasis, and Responsiveness to Steroid Hormones.
    Ren YA; Mullany LK; Liu Z; Herron AJ; Wong KK; Richards JS
    Cancer Res; 2016 Apr; 76(8):2206-18. PubMed ID: 26964623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel CRISPR/Cas9-mediated Mouse Model of Colon Carcinogenesis.
    Kashima H; Fischer A; Veronese-Paniagua DA; Gazit VA; Ma C; Yan Y; Levin MS; Madison BB; Rubin DC
    Cell Mol Gastroenterol Hepatol; 2024 Aug; 18(5):101390. PubMed ID: 39128652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-species analysis of genetically engineered mouse models of MAPK-driven colorectal cancer identifies hallmarks of the human disease.
    Belmont PJ; Budinska E; Jiang P; Sinnamon MJ; Coffee E; Roper J; Xie T; Rejto PA; Derkits S; Sansom OJ; Delorenzi M; Tejpar S; Hung KE; Martin ES
    Dis Model Mech; 2014 Jun; 7(6):613-23. PubMed ID: 24742783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mouse models for human colorectal cancer with liver metastasis].
    Huang XD; Zheng YB; Yang YJ; Yang C; Li HL; Cheng HR
    Zhonghua Yi Xue Za Zhi; 2019 Sep; 99(34):2701-2705. PubMed ID: 31505723
    [No Abstract]   [Full Text] [Related]  

  • 9. Intestinal cancer progression by mutant p53 through the acquisition of invasiveness associated with complex glandular formation.
    Nakayama M; Sakai E; Echizen K; Yamada Y; Oshima H; Han TS; Ohki R; Fujii S; Ochiai A; Robine S; Voon DC; Tanaka T; Taketo MM; Oshima M
    Oncogene; 2017 Oct; 36(42):5885-5896. PubMed ID: 28628120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine.
    Davies EJ; Marsh Durban V; Meniel V; Williams GT; Clarke AR
    J Pathol; 2014 May; 233(1):27-38. PubMed ID: 24293351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse models of colorectal cancer: Past, present and future perspectives.
    Bürtin F; Mullins CS; Linnebacher M
    World J Gastroenterol; 2020 Apr; 26(13):1394-1426. PubMed ID: 32308343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Mutation of
    Sakai E; Nakayama M; Oshima H; Kouyama Y; Niida A; Fujii S; Ochiai A; Nakayama KI; Mimori K; Suzuki Y; Hong CP; Ock CY; Kim SJ; Oshima M
    Cancer Res; 2018 Mar; 78(5):1334-1346. PubMed ID: 29282223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Priceless GEMMs: genetically engineered mouse models for colorectal cancer drug development.
    Roper J; Hung KE
    Trends Pharmacol Sci; 2012 Aug; 33(8):449-55. PubMed ID: 22739258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis in APC, KRAS, and TP53 in patients with stomach and colon cancer.
    Palacio-Rúa KA; Isaza-Jiménez LF; Ahumada-Rodríguez E; Muñetón-Peña CM
    Rev Gastroenterol Mex; 2014; 79(2):79-89. PubMed ID: 24861525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GEMMs as preclinical models for testing pancreatic cancer therapies.
    Gopinathan A; Morton JP; Jodrell DI; Sansom OJ
    Dis Model Mech; 2015 Oct; 8(10):1185-200. PubMed ID: 26438692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic profiling of a mouse model of acute intestinal Apc deletion leads to identification of potential novel biomarkers of human colorectal cancer (CRC).
    Hammoudi A; Song F; Reed KR; Jenkins RE; Meniel VS; Watson AJ; Pritchard DM; Clarke AR; Jenkins JR
    Biochem Biophys Res Commun; 2013 Oct; 440(3):364-70. PubMed ID: 23998936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse model of proximal colon-specific tumorigenesis driven by microsatellite instability-induced Cre-mediated inactivation of Apc and activation of Kras.
    Kawaguchi Y; Hinoi T; Saito Y; Adachi T; Miguchi M; Niitsu H; Sasada T; Shimomura M; Egi H; Oka S; Tanaka S; Chayama K; Sentani K; Oue N; Yasui W; Ohdan H
    J Gastroenterol; 2016 May; 51(5):447-57. PubMed ID: 26361962
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Chung WJ; Daemen A; Cheng JH; Long JE; Cooper JE; Wang BE; Tran C; Singh M; Gnad F; Modrusan Z; Foreman O; Junttila MR
    Proc Natl Acad Sci U S A; 2017 Dec; 114(51):E10947-E10955. PubMed ID: 29203670
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinicopathological and mutational differences between tumors with multiple metastases and single lung metastasis in colorectal cancer.
    Yanai Y; Hayashi T; Akazawa Y; Yatagai N; Tsuyama S; Yao T; Saito T
    Oncol Lett; 2020 Jul; 20(1):541-550. PubMed ID: 32565980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes.
    Takeda H; Kataoka S; Nakayama M; Ali MAE; Oshima H; Yamamoto D; Park JW; Takegami Y; An T; Jenkins NA; Copeland NG; Oshima M
    Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15635-15644. PubMed ID: 31300537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.